Amlodipine Besylate Tablet
Product Images NDC 51407-951

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 51407-951). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gsms, Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstruc (Chemstruc)

Chemical structure of the active ingredient Amlodipine Besylate, showing its molecular arrangement with atoms and bonds, including a chlorophenyl ring and amine group, with the molecular formula C6H6O3S noted below the structure.*

FDA Label Image

Containerlabel10mg1000cc (Containerlabel10mg1000cc)

The label for Amlodipine Besylate Tablets, USP, 10 mg strength, displays the product name prominently along with the dosage strength inside a purple box. It indicates a quantity of 1000 tablets and specifies the prescription-only status. The label includes storage instructions, warnings to keep out of reach of children, and details about the marketer GSMS, Incorporated and manufacturer CorePharma, LLC. A barcode and a serialization area are also visible on the right side.*

FDA Label Image

Containerlabel10mg90cc (Containerlabel10mg90cc)

Label for Amlodipine Besylate Tablets, USP 10 mg, oral tablets, in a bottle of 90 count. The label includes the NDC 51407-951-90 and states it is marketed by GSMS, Incorporated and manufactured by CorePharma, LLC. It also contains storage instructions and a barcode on the right side with a Serialization Area.*

FDA Label Image

Containerlabel5mg1000cc (Containerlabel5mg1000cc)

Label for Amlodipine Besylate Tablets, USP 5 mg oral tablets. The label indicates a count of 1000 tablets and is marked for prescription use only. It is marketed by GSMS, Incorporated and manufactured by CorePharma, LLC. The label includes storage instructions and patient information warnings.*

FDA Label Image

Containerlabel5mg90cc (Containerlabel5mg90cc)

Amlodipine Besylate Tablets, USP 5 mg oral tablets packaging label. The label indicates 90 tablets per container with instructions for the pharmacist to dispense with a patient information leaflet. It includes storage conditions, manufacturer (CorePharma, LLC), and marketer (GSMS, Incorporated) details, with a barcode and serialization area on the right side.*

FDA Label Image

Fig1 (Fig1)

A Kaplan-Meier curve graph displaying event rate over time (months) for Amlodipine versus Placebo. The graph shows separate event rate curves labeled for Amlodipine and Placebo, with a p-value of 0.003 and hazard ratio of 0.691 (95% CI 0.54 to 0.88). The x-axis marks time up to 24 months, and the y-axis shows event rate from 0.0 to 0.25.*

FDA Label Image

Fig2 (Fig2)

A forest plot showing the hazard ratio with 95% confidence intervals for various patient subgroups comparing Amlodipine versus placebo. The horizontal axis represents the hazard ratio on a scale from 0.0 to 2.0, with a vertical line at 1.0 indicating no difference. Subgroups include age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata, each with corresponding sample sizes. Most hazard ratios are below 1.0, favoring Amlodipine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.